Corticosteroid resistance and disease

Annals of Medicine

Volumn 29, Issue 1, 1997, Pages 79-82

  DeRijk, Roel ^a   Sternberg, Esther M ^b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Glucocorticoid receptor; Glucocorticoids; Pathology; Resistance

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOIMMUNITY; DEPRESSION; ETIOLOGY; GENE MUTATION; HUMAN; LEUKEMIA; NELSON SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; SIDE EFFECT;

EID: 0031029453     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899708998746     Document Type: Short Survey

References (27)

1. Moalli PA, Rosen ST. Glucocorticoid receptors and resistance to glucocorticoids in hematological malignancies. Leuk Lymphoma 1994; 15: 363-74.
2. de Kloet ER. Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 1991; 12: 95-164.
3. Funder JW. Mineralocorticoids, glucocorticoids, receptors and response elements. Science 1993; 259: 1132-3.
4. Marx J. How the glucocorticoids suppress immunity. Science 1995; 270: 232-3.
5. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 1996; 17: 245-61.
6. Lamberts SWJ, Huizinga ATM, de lange P, de Jong FH, Koper JW. Clinical aspects of glucocorticoid sensitivity. Steroids 1996; 61: 157-60.
7. Chrousos GP, Detera-Wadleigh SD, Karl M. Syndromes of glucocorticoid resistance. Ann Intern Med 1993; 119: 1113-24.
8. Karl M, von Wichert G, Kempter E, et al. Nelson's syndrome associated with a somatic frameshift mutation in the glucocorticoid receptor gene. J Clin Endocrinol Metab 1996; 81: 124-9.
9. Kaspers GJL, Pieters R, Klumper E, de Waal FC, Veerman AJP. Glucocorticoid resistance in childhood leukemia. Leuk Lymphoma 1994; 13: 187-201.
10. Weaver JU, Hitman GA, Kopelman PG. An association between a Bcll restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia. J Mol Endocrinol 1992; 9: 295-300.
11. Panarelli M, Fraser R. The glucocorticoid receptor and hypertension. Endocr Res 1994; 20: 101-16.
12. DeRijk RH, Petrides J, Deuster P, Gold PW, Sternberg EM. Changes in corticosteroid-sensitivity of peripheral blood lymphocytes following strenuous exercise in humans. J Clin Endocrinol Metab 1996; 81: 228-35.
13. Norbiato G, Bevilacqua M, Vago T, et al. Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992; 74: 608-13.
14. Schlaghecke R, Kornely E, Wollenhaupt J, Specker C. Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum 1992; 35: 740-4.
15. Tanaka H, Akama H, Ichikawa Y, Makino I, Homma M. Glucocorticoid receptor in patients with lupus nephritis: relationship between receptor levels in mononuclear leukocytes and effect of glucocorticoid therapy. J Rheumatol 1992; 19: 878-83.
16. Adcock IM, Lane SJ, Brown CR, Peters MJ, Lee TH, Barnes PJ. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 1995; 154: 3500-5.
17. Sher ER, Leung DYM, Surs W. Steroid-resistant asthma: cellular mechanism contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994; 93: 33-9.
18. Sternberg EM. The stress response and the regulation of inflammatory disease. Ann Intern Med 1992; 117: 854-66.
19. Ramirez F, Fowell DJ, Puklavec M, Sommonds S, Mason D. Glucocorticoids promote a Th2 cytokine response by CD4+ T-cells in vitro. J Immunol 1996; 156.
20. Schobitz B, Sutanto W, Carey MP, Holsboer F, de Kloet ER. Endotoxin and interleukin-1 decrease the affinity of hippocampal mineralocorticoid (type I) receptor in parallel to activation of the hypothalamic-pituitary-adrenal axis. Neuroendocrinology 1994; 60: 124-33.
21. Hill MR, Stith RD, McCallum RE. Human recombinant IL-1 alters glucocorticoid receptor function in reuber hepatoma cells. J Immunol 1988; 141: 1522-8.
22. Kam JC, Szefler SJ, Surs W, Sher W, Leung DYM. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 1993; 151: 3460-6.
23. Gold PW, Loriaux DL, Roy A, et al. Responses to corticotropin-releasing hormone in the hypercorticolism of depression and Cushing's disease. Pathophysiological and diagnostic implications. N Engl J Med 1986; 314: 1329-35.
24. Brady LS, Whitfield HJ, Fox RJ, Gold PW, Herkenham M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. J Clin Invest 1991; 87: 831-7.
25. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996; 17: 187-205.
26. Gold WP, Goodwin FK, Chrousos GP. I. Clinical and biochemical manifestations of depression; relation to the neurobiology of stress. N Eng J Med 1988; 319: 348-53.
27. Gold WP, Goodwin FK, Chrousos GP. II. Clinical and biochemical manifestations of depression; relation to the neurobiology of stress. N Eng J Med 1988; 319: 413-20.